project id: TCGA-KIRP; case submitter id: TCGA-B3-8121; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; concentration: 0.16; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.55; rna integrity number: 8.4; age at index: 48; days to birth: -17760; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Alive; year of birth: 1963; age at diagnosis: 17760; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage I; ajcc pathologic t: T1; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 379.0; icd 10 code: C64.1; last known disease status: not reported; morphology: 8260/3; primary diagnosis: Papillary adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Kidney, NOS; synchronous malignancy: No; tissue or organ of origin: Kidney, NOS; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.8; longest dimension: 0.8; oct embedded: No; shortest dimension: 0.6; portion submitter id: TCGA-B3-8121-01A-21; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 10.0; percent necrosis: 8.0; percent neutrophil infiltration: 10.0; percent normal cells: 0.0; percent stromal cells: 32.0; percent tumor cells: 60.0; percent tumor nuclei: 60.0;